The Girona Biomedical Research Institute (IDIBGI), the Dr. Josep Trueta Hospital, the Jordi Gol Primary Care Research Institute (IDIAPJGol) and the University of Girona (UdG) have created a spin-off company dedicated to the development of digital health tools for acute care. This new technology company, called Myosafe, was set up this summer and is the result of research carried out in this field, led by Dr. Jaime Aboal, IDIBGI researcher and cardiologist at the Trueta Hospital, and Dr. Rafel Ramos, IDIBGI researcher, IDIAPJGol researcher and professor at the UdG.
Pre-hospital care of a patient encompasses everything that happens until the person is treated, including transfer to the health centre or diagnosis. This phase is key to the prognosis and evolution of a pathology, especially if it is an acute clinical problem, i.e. a disease that starts quickly and abruptly, such as a myocardial infarction. New technologies open up a new field of possibilities to explore new tools that can be integrated into this process to make it more efficient.
This has been the focus of the research of Drs Aboal and Ramos, who in recent years have been investigating ways to design and implement digital solutions to optimise the process that patients with acute illnesses follow from the first contact with healthcare professionals.
One example of success has been the creation of the ODISEA App, a digital tool that streamlines the management of acute myocardial infarction from the moment the person gives the warning signal. This application has been recognised with six awards from cardiology societies and public institutions for its innovative character in the management of the infarction code using telemedicine tools.
‘The creation of this new spin-off is the result of years of research and aims to bring new technologies to the maximum number of patients so that they can benefit from them,’ stresses Dr. Jaime Aboal.
‘This new applied technological innovation company contributes to positioning the Girona Health Region as a driving force behind the entrepreneurial network in health’, says Dr. Rafel Ramos, who adds that ‘the Myosafe spin-off has been made possible thanks to the close collaboration between different key institutions in the Girona ecosystem of research and health’.
